世名科技(300522.SZ):2019年淨利預增0%–20%
格隆匯1月17日丨世名科技(300522.SZ)披露2019年年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為6722.58萬元至8067.10萬元,同比增長0%–20%。業績變動原因如下:
1、報告期內,公司嚴格按照既定的發展規劃和經營目標,進一步加大對市場的開拓力度,強化品牌效應與營銷渠道建設,持續推進協同管理工作,整體經營情況保持良好態勢。經初步測算,2019年度公司營業收入、歸屬於上市公司股東的淨利潤均穩步增長。
2、報告期內,公司預計非經常性損益對淨利潤的影響金額約為527.55萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.